Why are investors buzzing about Novo Nordisk’s Wegovy pill launch? And how has sentiment turned against software makers like Salesforce? Plus, what drove BlackRock’s asset pile to a record $14 trillion? Host <a href="https://www.wsj.com/news/author/jack-pitcher?gaa_at=eafs&gaa_n=AWEtsqf9pboGatp3yX9U7zoI-kOTmAtV8DczIFmoV4yNf4KOhRyifavsD_dQTaLOzRc%3D&gaa_ts=696a6991&gaa_sig=0c8bJsJ8oKy8agsSQt1JiQiqHvYViPVgK_1-uNi0XSNOGcefeHy7vnIu-hASEqBUbr1p2CpOjqLk_p2kOi8GoA%3D%3D">Jack Pitcher</a> discusses the biggest stock moves of the week and the news that drove them.

Sign up for the WSJ's free <a href="https://www.wsj.com/newsletters/markets-am?mod=WSJ_YMBPOD">Markets A.M. newsletter</a>.
 Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

What’s News in Markets: Wegovy Pill, Salesforce AI Woes, BlackRock Record

WSJ Your Money Briefing

AI Chapters

AI Insights

Reviews